Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01471561 · ClinicalTrials.gov registry record
Analysis of Cataract Surgery Induced Dry Eye
A clinical trial, sponsored by TearLab Corporation.
- Completed
- Registry status
- 61
- Enrollment target
NCT01471561: Completed study, sponsored by TearLab Corporation.
NCT01471561 is a clinical trial that has completed, run by TearLab Corporation. The registered enrollment target is 61 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01471561 has completed, sponsored by TearLab Corporation.
- COMPLETED
- Registry status
- 61 participants
- Enrollment target
Study Summary
This is a retrospective study to determine if rates of osmolarity and dry eye disease symptoms increase following cataract surgery.
Primary Outcome
Correlation between pre-surgery value and development of dry eye disease post surgery 1\) Comparison of Osmolarity measurement pre to post-op, as well as over time, to determine change and statistical significance
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2011-10 |
| Est. Completion | 2012-09 |
What the finished NCT01471561 record still lists
NCT01471561 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 61 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01471561 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01471561 about?
NCT01471561 is a clinical study titled "Analysis of Cataract Surgery Induced Dry Eye". This is a retrospective study to determine if rates of osmolarity and dry eye disease symptoms increase following cataract surgery.
What is the current status of trial NCT01471561?
This trial is currently completed. The enrollment target is 61 participants. The study started on 2011-10. Estimated completion is 2012-09.
Who is sponsoring clinical trial NCT01471561?
This trial is sponsored by TearLab Corporation, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04115306 · 61 participants · Phase 1
Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer
- NCT05070845 · 61 participants · Phase 2
Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia
- NCT05187832 · 61 participants · Phase 1
A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer
- NCT05269316 · 61 participants · Phase 1
Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia